Press Releases

Catalent to Acquire RheinCell Therapeutics, Strengthening a Path…

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today…

(PRWeb June 24, 2021)

Read the full story at https://www.prweb.com/releases/catalent_to_acquire_rheincell_therapeutics_strengthening_a_path_towards_industrialization_of_induced_pluripotent_stem_cell_based_therapies/prweb18028966.htm

Read more: Catalent to Acquire RheinCell Therapeutics, Strengthening a Path...


Privacy Settings